These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37301934)

  • 21. The evolving use of hyperbaric oxygen therapy during the COVID-19 pandemic.
    El Hawa AAA; Charipova K; Bekeny JC; Johnson-Arbor KK
    J Wound Care; 2021 Feb; 30(Sup2):S8-S11. PubMed ID: 33573494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache.
    Bennett MH; French C; Schnabel A; Wasiak J; Kranke P; Weibel S
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD005219. PubMed ID: 26709672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing the effect of hyperbaric oxygen therapy in breast cancer patients with late radiation toxicity (HONEY trial): a trial protocol using a trial within a cohort design.
    Batenburg MCT; van den Bongard HJGD; Kleynen CE; Maarse W; Witkamp A; Ernst M; Doeksen A; van Dalen T; Sier M; Schoenmaeckers EJP; Baas IO; Verkooijen HM
    Trials; 2020 Nov; 21(1):980. PubMed ID: 33246494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperbaric oxygen therapy for mild traumatic brain injury persistent postconcussion syndrome: a randomized controlled trial.
    Harch PG; Andrews SR; Rowe CJ; Lischka JR; Townsend MH; Yu Q; Mercante DE
    Med Gas Res; 2020; 10(1):8-20. PubMed ID: 32189664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperbaric oxygen therapy for paediatric patients: an unintended consequence of the COVID-19 pandemic.
    El Hawa AAA; Bekeny JC; Phillips NW; Johnson-Arbor K
    J Wound Care; 2021 Sep; 30(Sup9):S24-S28. PubMed ID: 34554855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperbaric oxygen therapy for acute coronary syndrome.
    Bennett MH; Lehm JP; Jepson N
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD004818. PubMed ID: 26202854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac abnormalities in Long COVID 1-year post-SARS-CoV-2 infection.
    Roca-Fernandez A; Wamil M; Telford A; Carapella V; Borlotti A; Monteiro D; Thomaides-Brears H; Kelly M; Dennis A; Banerjee R; Robson M; Brady M; Lip GYH; Bull S; Heightman M; Ntusi N; Banerjee A
    Open Heart; 2023 Feb; 10(1):. PubMed ID: 36822818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.
    Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ
    Trials; 2021 May; 22(1):342. PubMed ID: 34001174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of Hyperbaric Oxygen Therapy in SARS-CoV-2 Pneumonia: The Primary Results of a Randomised Clinical Trial.
    Siewiera J; Brodaczewska K; Jermakow N; Lubas A; Kłos K; Majewska A; Kot J
    J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36614808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol.
    Mera-Cordero F; Bonet-Monne S; Almeda-Ortega J; García-Sangenís A; Cunillera-Puèrtolas O; Contreras-Martos S; Alvarez-Muñoz G; Monfà R; Balanzo-Joué M; Morros R; Salvador-Gonzalez B
    Trials; 2022 Jan; 23(1):19. PubMed ID: 34991703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Hyperbaric Oxygen Therapy on Long COVID: A Systematic Review.
    Wu BQ; Liu DY; Shen TC; Lai YR; Yu TL; Hsu HL; Lee HM; Liao WC; Hsia TC
    Life (Basel); 2024 Mar; 14(4):. PubMed ID: 38672710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperbaric oxygen in the treatment of childhood autism: a randomised controlled trial.
    Sampanthavivat M; Singkhwa W; Chaiyakul T; Karoonyawanich S; Ajpru H
    Diving Hyperb Med; 2012 Sep; 42(3):128-33. PubMed ID: 22987458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A COVID-19 infection incidentally detected during hyperbaric oxygen treatment and preventive measures for COVID-19 transmission in a multiplace hyperbaric chamber.
    Demir AE; Ilbasmis S; Toklu AS
    Diving Hyperb Med; 2022 Mar; 52(1):58-62. PubMed ID: 35313375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left ventricular global longitudinal strain imaging in identifying subclinical myocardial dysfunction among covid-19 survivors.
    Kujur PP; Jhala M; Bhondve A; Lanjewar C; Matta R; Deshmukh H
    Indian Heart J; 2022; 74(1):51-55. PubMed ID: 34933014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.